dual gip and glp-1 receptor agonist The Emerging Role of Agonists in Glycemic Management and Cardiovascular Risk Reduction Tirzepatide, a dual GIP/GLP-1 receptor

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

Glucagon-like peptide1 (GLP1) receptor agonists represent a powerful treatment option to aid in managing these complex conditions

The lack of effective, scalable interventions to treat the general increase in human body weight that marks the past 50 years has made obesity one of the major public health concerns worldwide

Ando, H

The prescribing information for these medications contains a boxed warning regarding the potential risk of thyroid C-cell tumors, a rare form of thyroid cancer